Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Evolus Inc before investing.

In this article, we go over a few key elements for understanding Evolus Inc’s stock price such as:

• Evolus Inc’s current stock price and volume
• Why Evolus Inc’s stock price changed recently
• Upgrades and downgrades for EOLS from analysts
• EOLS’s stock price momentum as measured by its relative strength

About Evolus Inc (EOLS)

Before we jump into Evolus Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Evolus, Inc. is a performance beauty company, which is focused on delivering products in the self-pay aesthetic market. Its first commercial product is Jeuveau, which is a 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance. Jeuveau is manufactured using Hi-Pure technology. The Company commercially launched Jeuveau in the United States. The Company manufactures both Jeuveau and BOTOX. BOTOX (onabotulinumtoxinA) is the neurotoxin approved 900 kDa botulinum toxin type A complex in the United States.

Want to learn more about Evolus Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Evolus Inc.

Evolus Inc’s Stock Price as of Market Close

As of November 21, 2023, 4:00 PM, CST, Evolus Inc’s stock price was $9.42.

Evolus Inc is down 4.27% from its previous closing price of $9.84.

During the last market session, Evolus Inc’s stock traded between $9.24 and $9.85. Currently, there are 57.02 million shares of Evolus Inc stock available for purchase.

Unfortunately, Evolus Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Evolus Inc Stock Price History

Evolus Inc’s (EOLS) price is currently up 23.95% so far this month.

During the month of November, Evolus Inc’s stock price has reached a high of $10.00 and a low of $7.44.

Over the last year, Evolus Inc has hit prices as high as $11.49 and as low as $6.51. Year to date, Evolus Inc’s stock is up 44.7%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Evolus Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 20, 2023, there was 1 analyst who downgraded Evolus Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Evolus Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Evolus Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Evolus Inc (EOLS) by visiting AAII Stock Evaluator.

Relative Price Strength of Evolus Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 20, 2023, Evolus Inc has a weighted four-quarter relative price strength of 3.64%, which translates to a Momentum Score of 81 and is considered to be Very Strong.

Want to learn more about how Evolus Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Evolus Inc Stock Price: Bottom Line

As of November 21, 2023, Evolus Inc’s stock price is $9.42, which is down 4.27% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Evolus Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.